Stockreport

Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update

Rapport Therapeutics, Inc.  (RAPP) 
PDF Completed initial public offering, raising $174.4 million in gross proceeds, including full exercise of the underwriters’ option to purchase additional shares and a conc [Read more]